Three studies back Bionano's optical genome mapping in blood cancers
Go back to Three studies back Bionano's optical genome mapping in blood cancers| (NASDAQ: BNGO) | Delayed: 1.76 -0.07 (3.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.83 | 52 Week High | $ | |||
| Open | $1.85 | 52 Week Low | $ | |||
| Day High | $1.87 | P/E | N/A | |||
| Day Low | $1.75 | EPS | $ | |||
| Volume | 235,286 | |||||

